Kidney Failure Drugs - Search News

chronic kidney disease, FDA

The New York Times · 1d

F.D.A. Approves Ozempic to Treat Kidney Disease

The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.

CNN on MSN · 1d

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,

BioPharma Dive · 5h

FDA clears use of Ozempic to protect kidney health

The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, which hasn’t yet proven it can improve outcomes in kidney disease.

14hon MSN

Novo’s Ozempic Gains US Nod for Kidney Disease, Widening Use

Novo Nordisk A/S’s blockbuster Ozempic won US approval to treat chronic kidney disease in patients who also have type 2 ...

1don MSN

Pain medication finds new purpose fighting toxins from kidney disease

Mefenamic acid, a common anti-inflammatory drug already approved for pain management, has been found to significantly reduce ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results